Company CHA Vaccine Research Institute
Equities
A261780
KR7261780001
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,890 KRW | +0.72% | -2.00% | -13.45% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccines and Diagnostic Reagents
100.0
%
| 179 | 100.0 % | 294 | 100.0 % | +63.87% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
100.0
%
| 179 | 100.0 % | 294 | 100.0 % | +63.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeong-Seon Yeom
CEO | Chief Executive Officer | 62 | 01/00/01 |
Jung-Ki Cho
PSD | President | 54 | 01/19/01 |
Seung-Rae Kim
AUD | Comptroller/Controller/Auditor | 66 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Min-Sik Park
BRD | Director/Board Member | 54 | 01/20/01 |
Jung-Jae Koh
BRD | Director/Board Member | 70 | 01/17/01 |
Dae-Gyu Oh
BRD | Director/Board Member | 71 | 01/21/01 |
Jeong-Seon Yeom
CEO | Chief Executive Officer | 62 | 01/00/01 |
Dong-Cheol Shin
BRD | Director/Board Member | 54 | 01/21/01 |
Yong-Ha Baek
BRD | Director/Board Member | 56 | 28/22/28 |
Jung-Ki Cho
PSD | President | 54 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,816,748 | 15,907,174 ( 59.32 %) | 0 | 59.32 % |
Company contact information
CHA Vaccine Research Institute Co., Ltd.
560 Dunchon-daero Jungwon-gu
13230, Seongnam-si
+
http://www.chavaccine.comSector
1st Jan change | Capi. | |
---|---|---|
-13.45% | 9.59Cr | |
+8.29% | 11TCr | |
+10.21% | 11TCr | |
+0.41% | 2.23TCr | |
-11.90% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.17% | 1.72TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- A261780 Stock
- Company CHA Vaccine Research Institute